TY  - GEN
AU  - Vilgrain,Valérie
AU  - Abdel-Rehim,Mohamed
AU  - Sibert,Annie
AU  - Ronot,Maxime
AU  - Lebtahi,Rachida
AU  - Castéra,Laurent
AU  - Chatellier,Gilles
TI  - Radioembolisation with yttrium‒90 microspheres versus sorafenib for treatment of advanced hepatocellular carcinoma (SARAH): study protocol for a randomised controlled trial
SN  - 1745-6215
PY  - 2015///0806
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Carcinoma, Hepatocellular
KW  - economics
KW  - Clinical Protocols
KW  - Cost-Benefit Analysis
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Drug Costs
KW  - Embolization, Therapeutic
KW  - France
KW  - Humans
KW  - Liver Neoplasms
KW  - Microspheres
KW  - Niacinamide
KW  - Phenylurea Compounds
KW  - Prospective Studies
KW  - Protein Kinase Inhibitors
KW  - Quality of Life
KW  - Research Design
KW  - Sorafenib
KW  - Time Factors
KW  - Treatment Outcome
KW  - Yttrium Radioisotopes
KW  - administration & dosage
N1  - Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1186/1745-6215-15-474
ER  -